drugset / Trial / NCT05552391

Dexametomedine Versus Ketamine as an Adjuvant in Erector Spinae Block for Perioperative Thoracotomy Pain Control

NCT05552391 ↗

Phase 4 Completed 90 enrolled Kasr El Aini Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A double-blind randomized control study to compare the efficacy of dexmedetomidine versus ketamine as an adjuvant in combination with bupivacaine ultrasound-guided ESP block in patients scheduled for cardiothoracic surgeries with thoracotomy incision.

Timeline

Start
2022-09-01
Primary completion
2023-03-01
Completion
2023-04-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Other
Comparator Ketamine Small molecule 2 mg/kg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 0.5 unknown Other

Indications

No indication recorded.